PHARMAPLUS ROCOURT
ActiveSummary
The computed 12-month bankruptcy probability of PHARMAPLUS ROCOURT is 2.8% (moderate). The 2025 annual accounts show negative equity (-€28,859) and a net result of €32,216. Equity is growing by about 33% per year across the filed financial years. Its solvency ranks better than 10% of 5,019 sector peers (NACE 47, financial year 2025). The company has been active since 1979 and the Belgian Official Gazette contains no insolvency or warning signals.
History
On 30 March 1979, PHARMAPLUS ROCOURT was incorporated.1 The name was changed to PHARMA FORME in 2023 and to PHARMAPLUS ROCOURT in 2026.23 In 2026 the registered office moved to Rocourt.3 Total assets went from €679,702 in 2018 to €400,037 in 2025 and headcount from 2.7 to 3.3 full-time equivalents.4
Acts, filings and financial milestones
08-09
Gazette deed
Resignation: VSF MANAGEMENT (director)Appointment: GFB MANAGEMENT (director) · Permanent representative: Roel Fiey · Name change8 facts ▸
- Name change, PHARMAPLUS ROCOURT
- Director resignation, VSF MANAGEMENT (director (not named in the articles))
- Director appointment, GFB MANAGEMENT (director (not named in the articles))
- Permanent representative, Roel Fiey
- Registered-office move, 4000 Rocourt, Chaussée de Tongres 431
- Board meeting, “charge l'organe de direction de mettre en œuvre les décisions prises, assemblée générale” (deed in French)
- Other provision, “charge le notaire d'établir et de signer la version coordonnée des statuts et d'en assurer le dépôt dans le dossier de la société” (deed in French)
- Registered office clause, “4000 Rocourt, Chaussée de Tongres 431” (deed in French)
22-05
Gazette deed
Resignation: PHARMA INVEST MANAGEMENT SRL (director)Permanent representatives: PIRENNE Hubert and Fiey Roel · Appointment: VSF MANAGEMENT SRL (director)7 facts ▸
- General meeting, 01-04-2026
- Director resignation, PHARMA INVEST MANAGEMENT SRL (director)
- Permanent representative, PIRENNE Hubert
- Director appointment, VSF MANAGEMENT SRL (director)
- Board meeting, 31-03-2026
- Permanent representative, Fiey Roel (2 times)
- Director in office, VSF MANAGEMENT SRL (director)
19-12
Gazette deed
Resignation: PHARMA INVEST MANAGEMENT (manager)Reappointment: PHARMA INVEST MANAGEMENT (director) · Permanent representative: PIRENNE Hubert · Legal-form conversion15 facts ▸
- General meeting, 05-12-2023
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “suppression compte capitaux propres statutairement indisponible, fonds disponibles pour distribution” (deed in French)
- Other provision, “organe d'administration, possibilité distribution acomptes sur dividendes” (deed in French)
- Name change, PHARMA FORME
- Purpose change
- Amendment of the articles
- Capital
- Director resignation, PHARMA INVEST MANAGEMENT (manager)
- Director reappointment, PHARMA INVEST MANAGEMENT (director (not named in the articles))
- Permanent representative, PIRENNE Hubert (2 times)
- +3 further facts in this act
Show earlier events
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 3 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.